205 related articles for article (PubMed ID: 20470305)
21. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
22. Importance of iron supply for erythropoietin therapy.
Sunder-Plassmann G; Hörl WH
Nephrol Dial Transplant; 1995 Nov; 10(11):2070-6. PubMed ID: 8643170
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
Kim JM; Ihm CH; Kim HJ
Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
[TBL] [Abstract][Full Text] [Related]
24. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?
Kalantar-Zadeh K; Kalantar-Zadeh K; Lee GH
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S9-18. PubMed ID: 17699375
[TBL] [Abstract][Full Text] [Related]
25. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
[TBL] [Abstract][Full Text] [Related]
26. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
[TBL] [Abstract][Full Text] [Related]
27. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
Bhandari S; Naudeer S
J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
[TBL] [Abstract][Full Text] [Related]
28. Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?
Macdougall IC
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V73-78. PubMed ID: 15284364
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive vision for intravenous iron therapy.
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
[TBL] [Abstract][Full Text] [Related]
30. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.
Rosenlöf K; Kivivuori SM; Grönhagen-Riska C; Teppo AM; Slimes MA
Clin Nephrol; 1995 Apr; 43(4):249-55. PubMed ID: 7606879
[TBL] [Abstract][Full Text] [Related]
31. Response of hemoglobin, serum ferritin, and serum transferrin receptor during iron supplementation in pregnancy: a prospective study.
Madhavan Nair K; Bhaskaram P; Balakrishna N; Ravinder P; Sesikeran B
Nutrition; 2004 Oct; 20(10):896-9. PubMed ID: 15474878
[TBL] [Abstract][Full Text] [Related]
32. Iron deficiency in the acute-phase reaction after open aortic surgery.
Solis JV; Portero JL; Diaz J; Garcia R; Ligero JM; Vazquez E; Lodeiro C; Ballesteros L
Vasc Endovascular Surg; 2006; 40(5):392-8. PubMed ID: 17038573
[TBL] [Abstract][Full Text] [Related]
33. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.
Carrero JJ; Bárány P; Yilmaz MI; Qureshi AR; Sonmez A; Heimbürger O; Ozgurtas T; Yenicesu M; Lindholm B; Stenvinkel P
Nephrol Dial Transplant; 2012 Feb; 27(2):709-15. PubMed ID: 21617198
[TBL] [Abstract][Full Text] [Related]
34. Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study.
Krafft A; Perewusnyk G; Hänseler E; Quack K; Huch R; Breymann C
BJOG; 2005 Apr; 112(4):445-50. PubMed ID: 15777442
[TBL] [Abstract][Full Text] [Related]
35. Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
Szczech LA; Bregman DB; Harrington RA; Morris D; Butcher A; Koch TA; Goodnough LT; Wolf M; Onken JE
Nephrol Dial Transplant; 2010 Jul; 25(7):2368-75. PubMed ID: 20466657
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
Chang J; Bird R; Clague A; Carter A
Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
[TBL] [Abstract][Full Text] [Related]
37. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
[TBL] [Abstract][Full Text] [Related]
38. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
39. Triumph and tragedy: anemia management in chronic kidney disease.
Novak JE; Szczech LA
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
[TBL] [Abstract][Full Text] [Related]
40. [Issues related to iron replacement in dialyzed patients].
Kessler M
Nephrol Ther; 2006 Sep; 2 Suppl 4():S266-73. PubMed ID: 17373269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
